Hip Replacement Surgery
6
2
3
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 6 trials
100.0%
+13.5% vs benchmark
33%
2 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (6)
Nocturnal Low-dose Dexmedetomidine Infusion and Perioperative Sleep Quality
Mini-dose Dexmedetomidine-Esketamine Infusion and Perioperative Sleep Quality
OPPOSED (anteriOr hiP arthroPlasty regiOnal aneSthEsia stuDy) Study
Research on Multimodal Multi-objective Integrated Machine Algorithm for Hip Replacement Surgery
Korea Hip Replacement Surgery Registry
Efficacy and Safety of Fibrin Sealant Vapor Heated Solvent/Detergent Treated (FS VH S/D) for Hemostasis in Subjects Undergoing Total Hip Replacement